Table 3 Effect of PA intervention on HRQoL FACT-B and blood biomarker variables

FACT-B

 Intervention

108.56 (21.97)

114.41 (21.48)

5.91 (1.88 to 9.93)

5.05 (.69 to 9.40)

.25

.024

 Usual care

114.25 (18.97)

115.34 (17.57)

.56 (−3.43 to 4.56)

Reference

FACT-G

 Intervention

85.75 (17.35)

88.03 (18.53)

2.62 (−2.72 to 7.96)

2.17 (−1.43 to 5.78)

.14

.234

 Usual care

89.30 (13.23)

89.59 (16.84)

−.09 (−5.65 to 5.46)

Reference

TOI

 Intervention

65.29 (15.09)

72.59 (15.13)

7.20 (4.47 to 9.93)

5.64 (2.33 to 8.95)

.39

.001

 Usual care

71.13 (13.07)

73.25 (16.52)

2.13 (−1.89 to 6.14)

Reference

PWB

 Intervention

22.03 (5.25)

25.54 (9.32)

3.43 (.58 to 6.29)

.63 (−.87 to 2.13)

.13

.404

 Usual care

23.03 (4.39)

25.84 (9.18)

2.84 (−.15 to 5.84)

Reference

SWB

 Intervention

24.35 (4.44)

23.70 (5.03)

−.54 (−1.40 to .32)

−.73 (−2.03 to .59)

.17

.276

 Usual care

23.40 (4.19)

24.13 (4.13)

.19 (−1.00 to 1.37)

Reference

EWB

 Intervention

18.93 (4.61)

20.11 (4.14)

1.24 (.46 to 2.03)

.20 (−.85 to 1.26)

.05

.701

 Usual care

19.73 (3.74)

20.72 (3.30)

1.00 (.20 to 1.80)

Reference

FWB

 Intervention

20.45 (6.10)

21.95 (4.41)

1.76 (.21 to 3.30)

1.90 (.24 to 3.55)

.36

.025

 Usual care

23.15 (3.94)

22.88 (4.70)

−.16 (−1.25 to .94)

Reference

BCS

 Intervention

22.81 (6.67)

25.24 (7.13)

2.15 (.98 to 3.32)

2.84 (.79 to 4.89)

.42

.007

 Usual care

24.95 (6.79)

24.34 (6.21)

−75 (−2.81 to 1.31)

Reference

TC (mmol∙L⁻¹)

 Intervention

5.75 (1.30)

5.4 (1.09)

−.23 (−.49 to .04)

−.45 (−.71 to −.18)

−.38

.001

 Usual care

5.79 (1.04)

5.93 (.91)

.22 (.05 to .38)

Reference

HDL (mmol∙L⁻¹)

 Intervention

1.65 (.30)

1.62 (.33)

−.02 (−.12 to 0.79)

−.06 (−.15 to .04)

−.19

.264

 Usual care

1.59 (.34)

1.60 (.30)

.04 (−.03 to .10)

Reference

LDL (mmol∙L⁻¹)

 Intervention

3.44 (1.15)

3.18 (1.01)

−.19 (−.42 to .04)

−.30 (−.56 to −.04)

−.30

.023

 Usual care

3.56 (.84)

3.64 (.84)

.11 (−.11 to .32)

Reference

TC/HDL-C ratio (mmol∙L⁻¹)

 Intervention

3.61 (1.12)

3.47 (.93)

−.09 (−.36 to .09)

−.13 (−.40 to .14)

−.12

.337

 Usual care

3.79 (1.00)

3.83 (.90)

.04 (−.19 to .26)

Reference

Trig (mmol∙L⁻¹)

 Intervention

1.43 (.75)

1.31 (.58)

−.08 (−.21 to .05)

−.10 (−.27 to .07)

−.13

.240

 Usual care

1.52 (.85)

1.52 (.73)

.02 (−.14 to .18)

Reference

Glucose (mmol∙L⁻¹)

 Intervention

4.94 (.85)

4.81 (.52)

−.14 (−.36 to .09)

−.07 (−.38 to .25)

−.05

.683

 Usual care

5.27 (1.96)

5.32 (2.20)

−.08 (−.40 to .25)

Reference

Insulin (pmol∙L⁻¹)

 Intervention

38.37 (34.61)

37.40 (28.64)

−1.03 (15.37 to 13.31)

8.31 (−12.31 to 28.95)

.20

.425

 Usual care

45.45 (48.69)

37.34 (40.60)

−9.84 (−29.76 to 10.08)

Reference

HOMA

 Intervention

1.60 (1.18)

1.78 (.88)

.07 (−.62 to .76)

.42 (−.88 to 1.73)

.27

.520

 Usual care

2.18 (1.83)

1.90 (2.09)

−.41 (−2.09 to 1.26)

Reference